亚洲精品成人免费_91女神娇喘疯狂3p之夜_精品韩国一级久久_av毛片网_www超碰com_午夜视频体内射.COM.COM

美國(guó)RayBiotech
RayBiotech,Inc. 目前正致力于為后基因時(shí)代開(kāi)發(fā)創(chuàng)新，可靠的技術(shù)，在完成人類基因組序列之后，研究人員已經(jīng)能夠分析表達(dá)無(wú)數(shù)與疾病有關(guān)的基因。并且他們已經(jīng)率先開(kāi)發(fā)出高品質(zhì)的抗體和能夠同時(shí)有效地分析數(shù)百種有關(guān)炎癥，血管生成，細(xì)胞凋亡，細(xì)胞生長(zhǎng)和從一個(gè)單一的生物樣品信號(hào)轉(zhuǎn)導(dǎo)的蛋白表達(dá)結(jié)果的蛋白質(zhì)陣列技術(shù)。
產(chǎn)品簡(jiǎn)介如下：
Cytokine Antibody Array
Quantitative Antibody Array
Apoptosis Array
Phosphorylation Antibody Array
Enzyme Immunoassay (EIA) Based Kits
Protein Array
RayBio® ELISA kit
L Series: Label-Based Antibody Array
Tissue Microarray
Phosphorylation ELISA kit
Peptide & Peptide Synthesis

At RayBiotech, we are committed to developing innovative and reliable technologies for the post-genomic age. Our mission is to provide cutting edge proteomics tools for the advancement of basic and clinical research, the development of better patient diagnostics, and the facilitation of drug and biomarker discovery. It is also our mission to provide excellent service and support to our valued customers.

?

Following the completion of the human genome sequence, researchers have been able to analyze the expression of a myriad of disease-related genes. However, since many diseases result from abnormal protein expression, post-translational modifications, or interactions with other biomolecules, an understanding of disease states cannot be obtained from genomic research alone. It is our realization that high-throughput and efficient protein analysis offers the most promising approach for discovering novel drug targets, disease biomarkers and therapeutic agents.

At RayBiotech, we have pioneered the development of high quality antibody and protein array technology to efficiently analyze the concurrent expression and function of hundreds of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample. Thus, RayBiotech provides a reliable high-throughput technology for screening of novel biomarkers, identification of new drug targets, determination of key factors, as well as for accurate, early detection of diseases. Our technologies have the potential to contribute significantly to the realization of the heralded promise of personalized medicine for patients.
?